Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic evaluation of first intravenous dosing of quinolones in ICU patients with septic shock
2008-003484-39Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jul 2008
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of moxifloxacin, levofloxacin and ciprofloxacin in septic shock and Infection (3 arms), sponsored by Ghent University Hospital. Primary endpoint: Plasma levels of quinolones. Started Jul 2008; status: completed.
02
Drugs
moxifloxacinlevofloxacinciprofloxacin
03
Conditions
septic shockInfection
Beyond the preview
Go deeper on 2008-003484-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003484-39.